Acorda TV streaming ad for Parkinson’s drug resonates with viewers
Acorda Therapeutics executives were thinking about doing a broadcast TV commercial for its Parkinson’s drug Inbrija last year. However, as its VP of digital strategies Mike Russo pointed out, it was “very very expensive to do that.” So they looked around at other media options — and found a similar, but more cost effective strategy in streaming TV.
Acorda shot a 90-second commercial and debuted it across 50 streaming services including Disney, Hulu and Paramount in late March. It specifically targeted self-described households that were affected by Parkinson’s disease. In conjunction with the wide streaming ads, Acorda also launched complementary digital and social media ads to bolster its message.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters